décembre
Sui J, Cao W, Halkidis K, Abdelgawwad MS, Kocher NK, Guillory B, et al. Blood Adv 2019 ; 3 : 4177-86.
Atiq F, Schütte LM, Looijen AEM, Boender J, Cnossen MH, Eikenboom J, et al. Blood Adv 2019 ; 3 : 4147-54.
Jérôme ROLLIN Tribune’K Hémostase 2019 ; 3 (11) : A12. Davizon-Castillo P, McMahon B, Aguila S, Bark D, Ashworth K, Allawzi A, et al. TNF-α–driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging. Blood 2019 ; 134 : 727-40.
Fanny LASSALLE Tribune’K Hémostase 2019 ; 3 (11) : A11. Swystun LL, Ogiwara K, Rawley O, Brown C, Georgescu I, Homan W, et al. Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients. Blood 2019 ; 134 : 880-91.
novembre
Shao Y, Wu W, Xu G, Wang X, Ding Q. Blood 2019 ; 134 : 1745-54.
Fanny LASSALLE Tribune’K Hémostase 2019 ; 3 (10) : A10 Lyde RB, Sook Ahn H, Vo KK, Jarocha DJ, Tkaczynski J, Treffeisen E, et al. Infused factor VIII-expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A. Blood Adv 2019 ; 3 : 1368-78.
Lindström S, Wang L, Smith EN, Gordon W, van Hylckama Vlieg A, de Andrade M, et al. Blood 2019 ; 134 : 1645-57.
Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, et al. Lancet Haematol 2020 ; 7 : e18-e27.
octobre
Laurent FRENZEL Tribune’K Hémostase 2019 ; 3 (9) : A9 Arepally GM, Ortel TL. Bad weed: synthetic cannabinoid-associated coagulopathy. Blood 2019 ; 133 : 902-5.
Valsecchi C, Mirabet M, Mancini I, Biganzoli M, Schiavone L, Faraudo S, et al. Thromb Haemost 2019 ; 119 : 1767-72.
septembre
Jérôme ROLLIN Tribune’K Hémostase 2019 ; 3 (8) : A8 Marconi C, Di Buduo CA, LeVine K, Barozzi S, Faleschini M, Bozzi V. Loss-of-function mutations in PTPRJ cause a new form of inherited thrombocytopenia. Blood 2019 ; 133 : 1346-57.
août
Fanikos J, Murwin D, Gruenenfelder F, Tartakovsky I, França LR, Reilly PA, et al. Thromb Haemost 2020 ; 120 : 27-35.
Shapiro AD, Angchaisuksiri P, Astermark J, Benson G, Castaman G, Chowdary P, et al. Blood 2019 [Epub ahead of print]
juillet
Doshi BS, Rogers RS, Whitworth HB, Stabnick EA, Britton J, Butler RB, et al. J Thromb Haemost 2019 ; 17 : 1838-47.
Swystun LL, Ogiwara K, Rawley O, Brown C, Georgescu I, Hopman W, et al. Blood 2019 ; 134 : 880-91.
Davizon-Castillo P, McMahon B, Aguila S, Bark D, Ashworth K, Allawzi A, et al. Blood 2019 ; 134 : 727-40.
Laurent FRENZEL Tribune’K Hémostase 2019 ; 3 (7) : A7 Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med 2019 ; 380 : 711-9. et Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T. Rivaroxaban for […]
International Society on Thrombosis and Hemostasis Melbourne, Australie
juin
Zhao T, Houng A, Reed GL, et al. J Thromb Haemost 2019 ; 17 : 1461-69.
Annabelle DUPONT Tribune’K Hémostase 2019 ; 3 (6) : A6 Brehm MA, Hellermann N, Huck V, Klemm U, Obser T, Schneppenheim R. The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction. Blood 2019 ; 133 : 356-65.
mai
Cortesi PA, Castaman G, Trifirò G, Creazzola SS, Improta G, Mazzaglia G, et al. Thromb Haemost 2020 ; 120 : 216-28.
Levy GG, Asikanius E, Kuebler P, Benchikh El Fegoun S, Esbjerg S, Seremetis S. J Thromb Haemost 2019 ; 17 : 1470-7.
Kearon C, Parpia S, Spencer FA, Schulman S, Stevens SM, Shah V, et al. J Thromb Haemost 2019 ; 17 : 1144-52.
Fanny LASSALLE Tribune’K Hémostase 2019 ; 3 (5) : A5 Becker Y, Coupaye M, Elaïb Z, Kondratieff A, Lopez JJ, Zuber K. Platelet functions are decreased in obesity and restored after weight loss: evidence for a role of the SERCA-3 dependent ADP secretion pathway. N Engl J Med 2019 ; 380 : 711-9.
Hayward CPM, Moffat KA, Brunet J, Carlino SA, Plumhoff E, Meijer P, et al. Int J Lab Hematol 2019 ; 41 Suppl 1 : 26-32.
Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, et al. Gastroenterology 2019 ; 157 : 403-12.e5.
avril
Lyde RB, Ahn HS, Vo KK, Jarocha DJ, Tkaczynski J, Treffeisen E, et al. Blood Adv 2019 ; 3 : 1368-78.
Pipe SW, Shima M, Lehle M, Shapiro A, Chebon S, Fukutake K, et al. Lancet Haematol 2019 ; 6 : e295-e305.
Laurent FRENZEL Tribune’K Hémostase 2019 ; 3 (4) : A4 Behrendt N, Cooke EJ, Declerck PJ, Meijers JCM, von Drygalski A, Wyseure T. Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding. N Engl J Med 2018 ; 132 : 1593-603.
De la Morena-Barrio B, Borràs N, Rodríguez-Alén A, de la Morena-Barrio ME, García-Hernández JL, Padilla J, et al. Br J Haematol 2019 ; 186 : e82-6.
mars
Bhatt DL, Pollack CV, Weitz JI, Jennings LK, Xu S, Arnold SE, et al. N Engl J Med 2019 ; 380 : 1825-33.
Annabelle DUPONT Tribune’K Hémostase 2019 ; 3 (3) : A3 Candy V, Whithworth H, Grabell J, Thibeault L, Harpell L, Bowman M. A decreased and less sustained desmopressin response in haemophilia A carriers contributes to bleeding. Blood Adv 2018 ; 2 : 2629-36.
février
Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, et al. N Engl J Med 2019 ; 380 : 720-8.
Djambas Khayat C, El Khorassani M, Lambert T, Gay V, Barthez-Toullec M, Lamazure J, et al. J Thromb Haemost 2019 ; 17 : 635-44.
Pelland-Marcotte MC, Tucker C, Klaassen A, Avila ML, Amid A, Amiri N, et al. Lancet Haematol ; 6 : e144-53.
Fanny LASSALLE Tribune’K Hémostase 2019 ; 3 (2) : A2 Lai J, Swystun L, Cartier D, Nesbitt K, Zhang C, Hough C. N-linked glycosylation modulates the immunogenicity of recombinant human factor VIII in hemophilia A mice. Haematologica 2018 ; 103 : 1925‑36.
12th Annual Congress of European Association for Hemophilia and Allied Disorders Prague, République Tchèque
Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, et al. N Engl J Med 2019 ; 380 : 1326-35.
janvier
deVeber G, Kirkham F, Shannon K, Brandão L, Sträter R, Kenet G, et al. Haematologica 2019 ; 104 : 1676-81.
Leebeek FWG, et al. Blood 2019 ; 133 : 288-9.
Arepally GM, Ortel TL, et al. Blood 2019 ; 133 : 902-5.
Elaïb Z, Lopez JJ, Coupaye M, Zuber K, Becker Y, Kondratieff A, et al. Thromb Haemost ; 119 : 384-96.
Dong X, Leksa NC, Chhabra ES, Arndt JW, Lu Q, Knockenhauer KE, et al . Blood 2019 ; 133 : 1523-33.
Laurent FRENZEL Tribune’K Hémostase 2019 ; 3 (1) : A1 Mahlangu J, Oldenburg J, Paz-Priel I, Negrier C, Niggli M, Mancuso ME. Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors. N Engl J Med 2018 ; 379 : 811-22.
Scully M, Cataland SR, Peyvandi F, Coppo P, Knöbl P, Kremer Hovinga JA, et al. N Engl J Med 2019 ; 380 : 335-46.
